128936-04-9

Basic information

• Product Name: Benzenamine, 2-[(1H-imidazol-2-ylthio)methyl]-N-(2-methylpropyl)-
• CAS NO: 128936-04-9
• Molecular Formula: C14H19N3S
• Molecular Weight: 261.391
• Mol File: 128936-04-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenamine, 2-[(1H-imidazol-2-ylthio)methyl]-N-(2-methylpropyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 2-[(1H-imidazol-2-ylthio)methyl]-N-(2-methylpropyl)-(128936-04-9)
• EPA Substance Registry System: Benzenamine, 2-[(1H-imidazol-2-ylthio)methyl]-N-(2-methylpropyl)-(128936-04-9)

Safety Data

• Hazardous Substances Data: 128936-04-9(Hazardous Substances Data)

Upstream product

• 121385-36-2 2-isobutylaminobenzyl alcohol 
• 872-35-5 1,3-dihydro-imidazole-2-thione 
• 5344-90-1 2-Aminobenzyl alcohol 

Downstream Products

• 128936-05-0 N-isobutyl-2-<(2-imidazolylsulfinyl)methyl>aniline 

Relevant articles and documents

Method of reducing blood pressure

Disclosed is a method of reducing blood pressure which comprises administering to a patient an imidazole derivative of the formula: STR1 wherein: each of R1 and R2 is hydrogen, substituted or unsubstituted alkyl, alkoxyalkyl, cycloalkyl, aryl, aralkyl, or R1 and R2 are combined to form hetero ring; each of R3, R4, R5 and R6 is hydrogen, halogen, substituted or unsubstituted alkoxy, substituted or unsubstituted alkyl, aryl, aryloxy, alkoxycarbonyl, nitro, amino, acyl, or R3 is combined with R2 to form heteroring; R7 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted arylcarbonyl, or S-containing heteroring; each of R8 and R9 is hydrogen, halogen, substituted or unsubstituted alkoxy, unsubstituted or substituted alkyl, alkoxycarbonyl, aralkyl, nitro, amino, acyl, substituted or unsubstituted aryl, or R8 and R9 are combined to from alkylene; and n is 0 or 1.

Novel imidazole derivatives

Disclosed are novel imidazole derivatives having the formula: STR1 wherein R1 and R2 are H, alkyl, cycloalkyl, aryl, aralkyl or halogen-substituted alkyl, or R1 and R2 are combined to form a heterocyclic ring; R3, R4, R5 and R6 are H, halogen, alkoxy, aralkyloxy, alkyl, alkoxycarbonyl, nitro, amino, acyl, fluorine substituted-alkyl, or fluorine substituted-alkoxy, or R3 is combined with R2 to form a heterocyclic ring; R8 and R9 are H, halogen, alkoxy, alkyl, alkoxycarbonyl, nitro, amino, acyl, fluorine substituted-alkyl, fluorine substituted-alkoxy, or aryl group which may have a substituent, or R8 and R9 are combined to form an alicyclic ring; R7 is, where R8 and R9 are not combined, H, and, where R8 and R9 are combined, H, alkyl which may have a substituent, aryl which may have a substituent, arylcarbonyl which may have a substituent, or a sulfur-containing heterocyclic group; and n is 0 or 1. The new imidazole derivatives are effective particularly as anti-ulcer agents.